Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig

References

• Ameer B., Greenblatt D. J., Divoll M., Abernethy D. D., Shargel L. High-performance liquid chromatografic determination of acetaminophen in plasma: single-dose pharmaco-kinetics studies. Journal of Chromatography Biomedical Applications 1981; 226: 224–230
   PubMed Web of Science ®Google Scholar
• Armstrong S. G., Renton D. W. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice. Molecular Pharmacology 1993; 43: 542–547
   PubMed Web of Science ®Google Scholar
• Brockmeyer N. H., Mertins L., Spatz D., Tillmann I., Goos M. Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections. International Journal of Clinical Pharmacology, Therapy, and Toxicology 1992; 32: 530–533
   Google Scholar
• Caldwell J. Comparative aspects of detoxification in mammals. Enzymatic Basis of Detoxification, vol. 1, W. B. Jacoby. Academic, New York 1980; 85–114
   Google Scholar
• Campbell M. E., Grant D. M., Inaba T., Kalow W. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metabolism and Disposition 1987; 15: 237–249
   PubMed Web of Science ®Google Scholar
• Galtier P., Larrieu G., Tufenkji A. E., Franc M. Incidence of experimental fascioliasis on the activity of drug metabolizing enzymes in lamb liver. Drug Metabolism and Disposition 1986; 14: 137–141
   PubMed Web of Science ®Google Scholar
• Ghezzi P. B., Saccardo B., Bianchi M. Recombinan TNF depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochemical and Biophysical Research Communications 1986; 136: 316–321
   PubMed Web of Science ®Google Scholar
• Glazier A. P., Kokwaro G. O., Edwards G. Possible isozyme-specific effects of experimental malaria infection with Plasmodium berghei on cytochrome P450 activity in rat liver microsomes. Journal of Pharmacy and Pharmacology 1994; 46: 352–355
   PubMed Web of Science ®Google Scholar
• Heinzel G., Woloszcak R., Thomann P. TopFit 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Gustav Fischer, Stuttgart 1993
   Google Scholar
• Ismail S., Kokwaro G. O., Back D. J., Edwards G. Effect of malaria infection on the pharmacokinetics of paracetamol in rat. Xenobiotica 1994; 24: 527–533
   PubMed Web of Science ®Google Scholar
• Kalow W., Tang B. K. The use of caffeine for enzyme assays: a critical appraisal. Clinical Pharmacology and Therapeutics 1993; 53: 503–511
   PubMed Web of Science ®Google Scholar
• Kokwaro G. O., Szwandt S. F., Glazier A. P., Ward S. A., Edwards G. Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever. Xenobiotica 1993; 23: 1391–1397
   PubMed Web of Science ®Google Scholar
• Larsen K. Creatinine assay by a reaction-kinetic principle. Clinica et Chimica Acta 1972; 41: 209–215
   PubMed Web of Science ®Google Scholar
• van Leengoed L. A. M. G., Kamp E. M. Bronchoalveolar lavage in live pigs. Veterinary Quarterly 1989a; 11: 65–72
   PubMed Web of Science ®Google Scholar
• van Leengoed L. A. M. G., Kamp E. M. Endobronchial inoculation of various doses of Haemophilus (Actinobacillus) pleuropneumoniae in pigs. American Journal of Veterinary Research 1989b; 50: 2054–2059
   PubMedGoogle Scholar
• Mansor S. M., Edwards G., Roberts P. J., Ward S. A. The effect of malaria infection on paracetamol disposition in the rat. Biochemical Pharmacology 1991; 41: 1707–1711
   PubMed Web of Science ®Google Scholar
• Miert A. S. J., Van P. A. M. Influence of febrile disease on the pharmacokinetics of veterinary drugs. Annales de Recherces Vétérinaires 1990; 21: 11s–28s
   PubMedGoogle Scholar
• van Miert A. S. J. P. A. M. Acute phase response and non cellular defence mechanisms. Flemish Veterinary Journal 1991; 26: 69–91
   Google Scholar
• Miners J. O., Adams J. F., Birkett D. J. A simple hplc assay for urinary paracetamol metabolites and its use to characterize the C3H mouse as a model for paracetamol metabolism studies. Clinical Experimental Physiology and Pharmacology 1984; 11: 209–217
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette F. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 185–194
   PubMed Web of Science ®Google Scholar
• Monshouwer M., Witkamp R. F., Pijpers A., Verheijden J. H. M., van Miert A. S. J. P. A. M. Dose dependent pharmacokinetic interaction between antipyrine and paracetamol in vivo and in vitro when administered as a cocktail in the pig. Xenobiotica 1994; 24: 347–355
   PubMed Web of Science ®Google Scholar
• Monshouwer M., Witkamp R. F., Nijmeijer S. M., van Leengoed L. A. M. G., Verheijden J. H. M., van Miert A. S. J. P. A. M. Infection (Actinobacillus pleuropneumoniae) mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRMA levels in pigs. Drug Metabolism and Disposition 1995; 23: 44–47
   PubMed Web of Science ®Google Scholar
• Nielsen R. Serological characterization of Haemophilus pleuropneumoniae strains and proposal of a new serotype 9. Acta Veterinaria Scandinavia 1985; 26: 501–512
   PubMed Web of Science ®Google Scholar
• Okuno O., Kitao Y., Takasu M., Kano H., Kunieda K., Seki T., Shiozake Y., Sameshima Y. Depression of drug metabolizing activity in the human liver by interferon-α. European Journal of Clinical Pharmacology 1990; 39: 365–376
   PubMed Web of Science ®Google Scholar
• Pijpers A., Noordhuizen-Stassen E. N., Goedegebuure S. A., van Dobbenburgh O. A., Roosendaal M., Cornelissen A. H. M., Verheijden J. H. M. Intravenous catheterisation of conventional pigs without application of antimicrobial agents. Veterinary Quarterly 1989; 11: 216–221
   PubMed Web of Science ®Google Scholar
• Pijpers A., Schoevers E. J., van Gogh H., van Leengoed L. A. M. G., Visser I. J. R., Miert A. S. J. P. A. M., Verheijden J. H. M. The pharmacokinetics of oxytetracycline following intravenous administration in healthy and diseased pigs. Journal of Veterinary Pharmacology and Therapeutics 1990; 13: 320–326
   PubMed Web of Science ®Google Scholar
• Pous C., Giroud J. P., Damais C., Raichvarg D., Chauvelot-Moachon L. Effect of recombinant human interleukin-1 beta and tumor necrosis factor alpha on liver cytochrome P-450 and serum alpha-1-acid glycoprotein concentrations in the rat. Drug Metabolism and Disposition 1990; 18: 467–470
   PubMed Web of Science ®Google Scholar
• Renton K. W., Knickle L. C. Regulation of hepatic cytochrome P450 during infectious disease. Canadian Journal of Physiology and Pharmacology 1990; 68: 777–781
   PubMed Web of Science ®Google Scholar
• Rowland M., Benet L. Z., Graham G. G. Clearance concepts in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 1973; 1: 123–135
   PubMedGoogle Scholar
• Sebunya T. N. K., Saunders J. R. Haemophilus pleuropneumoniae infection in swine: a review. Journal of the American Veterinary Medical Association 1983; 182: 1331–1337
   PubMedGoogle Scholar
• Stanley L. A., Adams D. J., Lindsay R., Meehan R. R., Liao W., Wolf C. R. Potentiation and suppression of mouse liver cytochrome P450 isozymes during the acute phase response induced by bacterial endotoxin. European Journal of Biochemistry 1988; 174: 31–36
   PubMedGoogle Scholar
• Teunissen M. W. E., van den Meerburg-Torren J. E., Vermeulen N. P. E., Breimer D. D. Automated HPLC-determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4′-dihydroxy-antipyrine. Journal of Chromatography and Biomedical Applications 1983; 278: 367–378
   Google Scholar
• Vesell E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286
   PubMed Web of Science ®Google Scholar
• Watkins J. B., Klaassen C. D. Xenobiotic biotransformation in livestock: Comparison to other species used in toxicity testing. Journal of Animal Sciences 1986; 63: 933–942
   PubMed Web of Science ®Google Scholar
• Williams S. J., Baird-Lambert J. A., Farrell G. C. Inhibition of theophylline metabolism by interferon. Lancet 1987; ii: 939–941
   Google Scholar
• Williams S. J., Farrell G. C. Inhibition of antipyrine metabolism by interferon. British Journal of Clinical Pharmacology 1986; 22: 610–612
   PubMed Web of Science ®Google Scholar